ArticlePloS one2020
Identification of novel resistant sources for ascochyta blight (Ascochyta rabiei) in chickpea.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 62 citations in OpenAlex.
- Integrated Breeding Approaches for Ascochyta Blight Resistance in Chickpea.International journal of molecular sciences · 2026Review
- Exploring novel resistant sources for chilli leaf curl disease in Capsicum annuum L. germplasm for genetic enhancement.Scientific reports · 2026Article
- Metabarcoding insights into the fungal diversity and biotechnological potential of mangrove sediments in Ecuador's Reserva Ecológica Manglares Churute.Frontiers in fungal biology · 2026Article
- Advancing Chickpea Breeding: Omics Insights for Targeted Abiotic Stress Mitigation and Genetic Enhancement.Biochemical genetics · 2025Review
- Conventional gene stacking as a strategy to improve chickpea resistance to Ascochyta blight.Frontiers in plant science · 2025Article
- Identification of novel candidate genes for Ascochyta blight resistance in chickpea.Scientific reports · 2024Article
- Population-level whole-genome sequencing ofMicrobial genomics · 2024Article
- Resistance ofHeliyon · 2024Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Comparison of different screening methods for the selection of Ascochyta blight disease on chickpea (Frontiers in plant science · 2024Article
- Metabolite profiling of chickpea (Frontiers in plant science · 2024Article
- Ascochyta Blight in Chickpea: An Update.Journal of fungi (Basel, Switzerland) · 2023Review
- Stability and suitability of genotypes and environment to Ascochyta blight of chickpea.Frontiers in plant science · 2023Article
- Mining legume germplasm for genetic gains: An Indian perspective.Frontiers in genetics · 2023Review
- Ascochyta rabiei: A threat to global chickpea production.Molecular plant pathology · 2022Review
- A Comprehensive Review on Chickpea (International journal of molecular sciences · 2022Review
- Breeding and Genomics Interventions for Developing Ascochyta Blight Resistant Grain Legumes.International journal of molecular sciences · 2022Review
- Management of chickpea Ascochyta blight using fungicides and cultivar resistance improves grain yield, quality, and grower profitability.Frontiers in plant science · 2022Article
- The relationship between natural rain intensity and Ascochyta blight in chickpea development.European journal of plant pathology · 2022Article
- Genetic Diversity and Population Structure ofJournal of fungi (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chickpea (Cicer arietinum L.) is the second largest pulse crop grown worldwide and ascochyta blight caused by Ascochyta rabiei (Pass.) Labr. is the most devastating disease of the crop in all chickpea growing areas across the continents. The pathogen A. rabiei is highly variable. The resistant sources available are not sufficient and new sources needs to be identified from time to time as resistance breakdown in existing chickpea varieties is very frequent due to fast evolution of new pathotypes of the pathogen. Therefore, this work was undertaken to evaluate the existing chickpea germplasm diversity conserved in Indian National Genebank against the disease under artificial epiphytotic conditions. An artificial standard inoculation procedure was followed for uniform spread of the pathogen. During the last five winter seasons from 2014-15 to 2018-19, a total of 1,970 accessions have been screened against the disease and promising accessions were identified and validated. Screening has resulted in identification of some promising chickpea accessions such as IC275447, IC117744, EC267301, IC248147 and EC220109 which have shown the disease resistance (disease severity score ≤3) in multiple seasons and locations. Promising accessions can serve as the potential donors in chickpea improvement programs. The frequency of resistant and moderately resistant type accessions was comparatively higher in accessions originated from Southwest Asian countries particularly Iran and Syria than the accessions originated from Indian sub-continent. Further large scale screening of chickpea germplasm originated from Southwest Asia may result in identifying new resistant sources for the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.